Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: the JLCA and JSHBPS Expert Consensus Statement 2023

Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: the JLCA and JSHBPS Expert Consensus Statement 2023

Recent advances in systemic therapy for hepatocellular carcinoma (HCC) have led to debates about the feasibility of combination therapies, such as systemic therapy combined with surgery or transarterial chemoembolization, for patients with advanced HCC. However, a lack of consensus on the oncologica...

Full description

Bibliographic Details
Main Authors: Keiichi Akahoshi, Junichi Shindoh, Minoru Tanabe, Shunichi Ariizumi, Susumu Eguchi, Yukiyasu Okamura, Masaki Kaibori, Shoji Kubo, Mitsuo Shimada, Akinobu Taketomi, Nobuyuki Takemura, Hiroaki Nagano, Masafumi Nakamura, Kiyoshi Hasegawa, Etsuro Hatano, Tomoharu Yoshizumi, Itaru Endo, Norihiro Kokudo
Format: Article
Language:English
Published: Karger Publishers 2024-03-01
Series:Liver Cancer
Online Access:https://beta.karger.com/Article/FullText/538627

Internet

https://beta.karger.com/Article/FullText/538627

Similar Items